Has There Been Exacerbation of Disparities in Antimicrobial Resistance during the SARS-Cov-2 Pandemic?

Surg Infect (Larchmt). 2022 Sep;23(7):613-615. doi: 10.1089/sur.2022.099. Epub 2022 Jul 28.

Authors

Jennifer Rickard¹, David R Boulware², Weihua Guan³, Faustin Ntirenganya⁴, Susan Kline²

Affiliations

¹ Department of Surgery, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
² Division of Infectious Disease and International Medicine, Department of Medicine, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
³ Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
⁴ Department of Surgery, University of Rwanda, Kigali, Rwanda.

PMID: 35904537
DOI: 10.1089/sur.2022.099

No abstract available

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
COVID-19*
Drug Resistance, Bacterial
Humans
Pandemics
SARS-CoV-2*

Substances

Anti-Bacterial Agents